| Year |
Citation |
Score |
| 2020 |
Morotti M, Zois CE, El-Ansari R, Craze ML, Rakha EA, Fan SJ, Valli A, Haider S, Goberdhan DCI, Green AR, Harris AL. Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer. British Journal of Cancer. PMID 33028955 DOI: 10.1038/s41416-020-01113-y |
0.74 |
|
| 2019 |
Morotti M, Bridges E, Valli A, Choudhry H, Sheldon H, Wigfield S, Gray N, Zois CE, Grimm F, Jones D, Teoh EJ, Cheng WC, Lord S, Anastasiou D, Haider S, et al. Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 31152137 DOI: 10.1073/Pnas.1818521116 |
0.559 |
|
| 2019 |
Valli A, Morotti M, Zois CE, Albers PK, Soga T, Feldinger K, Fischer R, Frejno M, McIntyre A, Bridges E, Haider S, Buffa FM, Baban D, Rodriguez M, Yanes O, et al. Adaptation to HIF1α deletion in hypoxic cancer cells by upregulation of GLUT14 and creatine metabolism. Molecular Cancer Research : McR. PMID 30885992 DOI: 10.1158/1541-7786.MCR-18-0315 |
0.573 |
|
| 2018 |
Jones DT, Valli A, Haider S, Zhang Q, Smethurst EA, Schug ZT, Peck B, Aboagye EO, Critchlow SE, Schulze A, Gottlieb E, Wakelam MJO, Harris AL. 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers. Molecular Cancer Therapeutics. 18: 376-388. PMID 30478149 DOI: 10.1158/1535-7163.MCT-17-0857 |
0.69 |
|
| 2018 |
Leithner K, Triebl A, Trötzmüller M, Hinteregger B, Leko P, Wieser BI, Grasmann G, Bertsch AL, Züllig T, Stacher E, Valli A, Prassl R, Olschewski A, Harris AL, Köfeler HC, et al. The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 29844165 DOI: 10.1073/pnas.1719871115 |
0.536 |
|
| 2017 |
McCarthy MT, Moncayo G, Hiron TK, Jakobsen NA, Valli A, Soga T, Adam J, O'Callaghan CA. Purine nucleotide metabolism regulates expression of the human immune ligand MICA. The Journal of Biological Chemistry. PMID 29279329 DOI: 10.1074/jbc.M117.809459 |
0.393 |
|
| 2015 |
Valli A, Harris AL, Kessler BM. Hypoxia metabolism in ageing. Aging. 7: 465-6. PMID 26187134 |
0.458 |
|
| 2015 |
Valli A, Rodriguez M, Moutsianas L, Fischer R, Fedele V, Huang HL, Van Stiphout R, Jones D, Mccarthy M, Vinaxia M, Igarashi K, Sato M, Soga T, Buffa F, Mccullagh J, et al. Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways. Oncotarget. 6: 1920-41. PMID 25605240 DOI: 10.18632/Oncotarget.3058 |
0.742 |
|
| 2009 |
Rosner M, Fuchs C, Siegel N, Valli A, Hengstschläger M. New insights into the role of the tuberous sclerosis genes in leukemia. Leukemia Research. 33: 883-5. PMID 19286253 DOI: 10.1016/j.leukres.2009.02.013 |
0.358 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2009 |
Rosner M, Fuchs C, Siegel N, Valli A, Hengstschläger M. Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle. Human Molecular Genetics. 18: 3298-310. PMID 19505958 DOI: 10.1093/hmg/ddp271 |
0.292 |
|
| 2009 |
Burgstaller S, Rosner M, Lindengrün C, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M. Tuberin, p27 and mTOR in different cells. Amino Acids. 36: 297-302. PMID 18386114 DOI: 10.1007/S00726-008-0066-1 |
0.248 |
|
| 2008 |
Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M. The mTOR pathway and its role in human genetic diseases. Mutation Research. 659: 284-92. PMID 18598780 DOI: 10.1016/j.mrrev.2008.06.001 |
0.232 |
|
| 2010 |
Valli A, Rosner M, Fuchs C, Siegel N, Bishop CE, Dolznig H, Mädel U, Feichtinger W, Atala A, Hengstschläger M. Embryoid body formation of human amniotic fluid stem cells depends on mTOR Oncogene. 29: 966-977. PMID 19935716 DOI: 10.1038/Onc.2009.405 |
0.232 |
|
| 2009 |
Siegel N, Valli A, Fuchs C, Rosner M, Hengstschläger M. Expression of mTOR pathway proteins in human amniotic fluid stem cells. International Journal of Molecular Medicine. 23: 779-84. PMID 19424604 DOI: 10.3892/ijmm_00000192 |
0.206 |
|
| 2009 |
Garibotto G, Valli A, Anderstam B, Eriksson M, Suliman ME, Balbi M, Rollando D, Vigo E, Lindholm B. The kidney is the major site of S-adenosylhomocysteine disposal in humans. Kidney International. 76: 293-6. PMID 19357721 DOI: 10.1038/ki.2009.117 |
0.205 |
|
| 2008 |
Garibotto G, Russo R, Sofia A, Ferone D, Fiorini F, Cappelli V, Tarroni A, Gandolfo MT, Vigo E, Valli A, Arvigo M, Verzola D, Ravera G, Minuto F. Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases. Kidney International. 74: 937-45. PMID 18633341 DOI: 10.1038/ki.2008.345 |
0.187 |
|
| 2013 |
Roman HB, Hirschberger LL, Krijt J, Valli A, Kožich V, Stipanuk MH. The cysteine dioxgenase knockout mouse: altered cysteine metabolism in nonhepatic tissues leads to excess H2S/HS(-) production and evidence of pancreatic and lung toxicity. Antioxidants & Redox Signaling. 19: 1321-36. PMID 23350603 DOI: 10.1089/Ars.2012.5010 |
0.182 |
|
| 2009 |
Siegel N, Valli A, Fuchs C, Rosner M, Hengstschläger M. Induction of mesenchymal/epithelial marker expression in human amniotic fluid stem cells. Reproductive Biomedicine Online. 19: 838-46. PMID 20031026 DOI: 10.1016/j.rbmo.2009.09.015 |
0.18 |
|
| 2006 |
Garibotto G, Sofia A, Valli A, Tarroni A, Di Martino M, Cappelli V, Aloisi F, Procopio V. Causes of hyperhomocysteinemia in patients with chronic kidney diseases. Seminars in Nephrology. 26: 3-7. PMID 16412817 DOI: 10.1016/j.semnephrol.2005.06.002 |
0.179 |
|
| 2009 |
Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M. Skp2 inversely correlates with p27 and tuberin in transformed cells Amino Acids. 37: 257-262. PMID 18604603 DOI: 10.1007/S00726-008-0141-7 |
0.176 |
|
| 2009 |
Rosner M, Dolznig H, Fuchs C, Siegel N, Valli A, Hengstschläger M. CDKs as therapeutic targets for the human genetic disease tuberous sclerosis European Journal of Clinical Investigation. 39: 1033-1035. PMID 19744185 DOI: 10.1111/J.1365-2362.2009.02213.X |
0.172 |
|
| 2011 |
Ueki I, Roman HB, Valli A, Fieselmann K, Lam J, Peters R, Hirschberger LL, Stipanuk MH. Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide. American Journal of Physiology. Endocrinology and Metabolism. 301: E668-84. PMID 21693692 DOI: 10.1152/Ajpendo.00151.2011 |
0.171 |
|
| 2018 |
Huang H, van Dullemen LFA, Akhtar MZ, Faro ML, Yu Z, Valli A, Dona A, Thézénas ML, Charles PD, Fischer R, Kaisar M, Leuvenink HGD, Ploeg RJ, Kessler BM. Proteo-metabolomics reveals compensation between ischemic and non-injured contralateral kidneys after reperfusion. Scientific Reports. 8: 8539. PMID 29867102 DOI: 10.1038/S41598-018-26804-8 |
0.17 |
|
| 2010 |
Rosner M, Siegel N, Valli A, Fuchs C, Hengstschläger M. mTOR phosphorylated at S2448 binds to raptor and rictor. Amino Acids. 38: 223-228. PMID 19145465 DOI: 10.1007/S00726-008-0230-7 |
0.149 |
|
| 2007 |
Siegel N, Rosner M, Hanneder M, Valli A, Hengstschläger M. Stem cells in amniotic fluid as new tools to study human genetic diseases. Stem Cell Reviews. 3: 256-64. PMID 17955390 DOI: 10.1007/s12015-007-9003-z |
0.133 |
|
| 1999 |
Re L, Valli A, Barocci S, Giammarchi V, Serresi M, Faini T, Ricci M, Morales MA, León-Fernández OS. Effects of low ozone-oxygen concentrations on the acetylcholine release at the mouse neuromuscular junction. General Pharmacology. 32: 245-50. PMID 10188627 DOI: 10.1016/S0306-3623(98)00199-2 |
0.089 |
|
| 2008 |
Rosner M, Hanneder M, Siegel N, Valli A, Hengstschläger M. The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutation Research. 658: 234-46. PMID 18291711 DOI: 10.1016/j.mrrev.2008.01.001 |
0.085 |
|
| 2013 |
Valli A, Hirschberger L, Roman H, Stipanuk M. Hypercyst(e)inemia in CDO−/− mouse model is associated with an accumulation of tissue acid-labile sulfide and low circulating homocysteine levels Nutrition, Metabolism and Cardiovascular Diseases. 23: S52. DOI: 10.1016/j.numecd.2013.10.006 |
0.085 |
|
| 2008 |
Anderstam B, Ann-Christin BH, Valli A, Stenvinkel P, Lindholm B, Suliman ME. Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. Clinica Chimica Acta; International Journal of Clinical Chemistry. 393: 114-8. PMID 18423381 DOI: 10.1016/j.cca.2008.03.029 |
0.071 |
|
| 2007 |
Valli A, Suliman ME, Meert N, Vanholder R, Lindholm B, Stenvinkel P, Watanabe M, Barany P, Alvestrand A, Anderstam B. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors. Clinica Chimica Acta; International Journal of Clinical Chemistry. 379: 87-94. PMID 17292872 DOI: 10.1016/j.cca.2006.12.026 |
0.056 |
|
| 2013 |
Mannucci I, Cappuccino L, Valli A, Sofia A, Russo R, Bonanni A, Verzola D, Garibotto G. Glutathione (GSH) degradation in peripheral tissues of patients with chronic kidney disease (CKD) Nutrition, Metabolism and Cardiovascular Diseases. 23: S54. DOI: 10.1016/J.NUMECD.2013.10.013 |
0.045 |
|
| 2008 |
Valli A, Carrero JJ, Qureshi AR, Garibotto G, Bárány P, Axelsson J, Lindholm B, Stenvinkel P, Anderstam B, Suliman ME. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients. Clinica Chimica Acta; International Journal of Clinical Chemistry. 395: 106-10. PMID 18565329 DOI: 10.1016/j.cca.2008.05.018 |
0.045 |
|
| 2017 |
Lee R, Fischer R, Charles PD, Adlam D, Valli A, Di Gleria K, Kharbanda RK, Choudhury RP, Antoniades C, Kessler BM, Channon KM. A novel workflow combining plaque imaging, plaque and plasma proteomics identifies biomarkers of human coronary atherosclerotic plaque disruption. Clinical Proteomics. 14: 22. PMID 28642677 DOI: 10.1186/s12014-017-9157-x |
0.04 |
|
| 2007 |
Garibotto G, Sofia A, Balbi M, Procopio V, Villaggio B, Tarroni A, Di Martino M, Cappelli V, Gandolfo MT, Valli A, Verzola D. Kidney and splanchnic handling of interleukin-6 in humans. Cytokine. 37: 51-4. PMID 17420140 DOI: 10.1016/j.cyto.2007.02.015 |
0.037 |
|
| Hide low-probability matches. |